News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Watson David O.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/06/2023 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 8,510 shares
@ $89.98, valued at
$765.7k
|
|
| 06/29/2023 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Gifted 12,750 shares
@ $0
Gifted 12,750 shares
@ $0 |
|
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 9,886 shares
@ $0
Paid exercise price by delivering 825 shares
@ $58.5, valued at
$48.3k
Granted 14,023 options to buy
@ $35.46, valued at
$497.3k
|
|
| 02/14/2023 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 532 shares
@ $51.21, valued at
$27.2k
|
|
| 01/30/2023 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 551 shares
@ $52.77, valued at
$29.1k
|
|
| 01/24/2023 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,034 shares
@ $52.05, valued at
$105.9k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2022 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Disposed of 1,875 shares
@ $0
Sold 5,000 shares
@ $50, valued at
$250k
Disposed of 11,250 options to buy
@ $44.9, valued at
$505.1k
|
|
| 02/14/2022 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 491 shares
@ $47.12, valued at
$23.1k
|
|
| 02/01/2022 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 650 shares
@ $38.59, valued at
$25.1k
|
|
| 01/25/2022 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 26,051 shares
@ $0
Granted 36,951 options to buy
@ $35.46, valued at
$1.3M
|
|
| 12/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 954 options to buy
@ $4.31, valued at
$4.1k
|
|
| 06/22/2021 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 489 options to buy
@ $4.31, valued at
$2.1k
|
|
| 06/01/2021 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 489 options to buy
@ $4.31, valued at
$2.1k
|
|
| 04/23/2021 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 489 options to buy
@ $4.31, valued at
$2.1k
|
|
| 03/23/2021 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 978 options to buy
@ $4.31, valued at
$4.2k
|
|
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 9,935 shares
@ $50, valued at
$496.8k
Sold 2,709 shares
@ $50.607, valued at
$137.1k
Sold 2,526 shares
@ $51.316, valued at
$129.6k
Sold 1,163 shares
@ $52.727, valued at
$61.3k
Sold 900 shares
@ $53.861, valued at
$48.5k
Sold 900 shares
@ $55.001, valued at
$49.5k
Sold 200 shares
@ $55.908, valued at
$11.2k
Exercised 9,935 options to buy
@ $13.85, valued at
$137.6k
Exercised 8,398 options to buy
@ $13.85, valued at
$116.3k
|
|
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2020 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 3,000 shares
@ $40.467, valued at
$121.4k
Exercised 15,000 options to buy
@ $2.67, valued at
$40.1k
|
|
| 08/09/2019 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $2.67, valued at
$13.4k
|
|
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2018 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 15,776 shares
@ $18.784, valued at
$296.3k
Exercised 32,818 options to buy
@ $2.67, valued at
$87.6k
|
|
| 05/30/2018 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Gifted 624 shares
@ $0
Exercised 624 options to buy
@ $2.67, valued at
$1.7k
|
|
| 02/21/2018 |
4
| Watson David O. (General Counsel) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $14.95, valued at
$373.8k
|
|
|
|